Clinical Trial Detail

NCT ID NCT02155088
Title BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

pancreatic adenocarcinoma

Therapies

Alpelisib + Gemcitabine + Nab-paclitaxel

Age Groups: adult

No variant requirements are available.